CHINA RISUN GP (01907) · Company profile · Eqvero

CHINA RISUN GP

01907HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	39.29 bn CNY	47.54 bn CNY	46.07 bn CNY	43.14 bn CNY	38.43 bn CNY
Cost of revenue	34.17 bn CNY	41.72 bn CNY	40.41 bn CNY	37.44 bn CNY	31.55 bn CNY
Selling, general and administrative expense	2.58 bn CNY	2.63 bn CNY	2.25 bn CNY	1.92 bn CNY	1.92 bn CNY
Operating profit after depreciation	1.09 bn CNY	1.3 bn CNY	1.38 bn CNY	2.59 bn CNY	3.71 bn CNY
Operating profit before depreciation	3.14 bn CNY	3.63 bn CNY	3.71 bn CNY	4.01 bn CNY	5.06 bn CNY
EBIT	1.09 bn CNY	1.3 bn CNY	1.38 bn CNY	2.59 bn CNY	3.71 bn CNY
EBITDA	3.14 bn CNY	3.63 bn CNY	3.71 bn CNY	4.01 bn CNY	5.06 bn CNY
Interest expense	1.34 bn CNY	1.32 bn CNY	1.32 bn CNY	1.07 bn CNY	983.78 m CNY
Profit before tax	183.24 m CNY	109.4 m CNY	681.75 m CNY	2.2 bn CNY	3.2 bn CNY
Income tax expense	48.55 m CNY	11.59 m CNY	-307.8 m CNY	343.99 m CNY	601.84 m CNY
Income before extraordinary items	58.01 m CNY	20.13 m CNY	860.81 m CNY	1.86 bn CNY	2.61 bn CNY
Common dividends	16.69 m CNY	33.82 m CNY	269.87 m CNY	584.12 m CNY	825.84 m CNY
Total dividends	16.69 m CNY	33.82 m CNY	269.87 m CNY	584.12 m CNY	825.84 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.